A Buy alert! Star Scientific Inc. (CIGX) Nasdaq
Seeking Alpha Analyst Since 2010
Dr. John L. Faessel is a seasoned and respected Wall Street professional with industry-wide recognition for expertise in market strategy and analysis. He is widely recognized for his insights in public companies. For over 25-years Dr. Faessel’s ON THE MARKET reports have been widely distributed to a throughout the world to an extensive list of financial institutions, investment banking firms, brokers, foundations, mutual funds, hedge funds and private high net worth investors.
Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
A Buy alert!
A Stock for the Ages – Maybe!
Star Scientific Inc. (CIGX) $4.50 Nasdaq
Obviously, there's a bunch going on with Star Scientific, as the shares have recently rocketed from $1.60 to $5.12 - but this story will really, really make you ponder on what's going on with the company and how their research is progressing.
The anecdotal story goes... that the a while back Richard L. Sharp the (former) Chairman of the Board of Crocs Inc. NYSE was part of a study at Roskamp Institute. He had taken a leave of absence from the company due to what was thought to be Alzheimer's. http://biz.yahoo.com/e/101203/crox8-k.html
Rumors were out there that he was the beneficiary of some kind of miraculous healing from this devastating illness after his experience at Roskamp. I repeat that this account about Mr. Sharp and his experience at Roskamp is 100% unsubstantiated, but the story got around.
That's interesting enough due to what we know of what's going on at the Roskamp Institute with their human Alzheimer studies etc...
Now, we hear that Mr. Sharp is a new board member of Star Scientific. No way. Right? http://www.starscientific.com/news/richard-l-sharp-former-board-chair-of-circuit-city-carmax-joins-star-scientific-board/
Mr. Sharp was also Chairman of Circuit City and Carmax
Star Scientific makes the product the Roskamp Institute uses for their Alzheimer studies.
Excuse me, as I reach for a couple of CigRx’s lozenges...
If true this is momentous news for Star Scientific and their shares as it not only validates, but hammers home much of what we have already thought about the progress of Roskamp’s activities.
This whole story about (CIGX) gets better and better, it's almost unreal. While the stock is well up from its long trading range with what's going on I think most stockholders think that the share price should be much higher. Naturally, this presents us with an opportunity to buy more.
If you missed my previous reports more specific in detail and scope to each of the above stated themes, or receive my Best Ideas for 2011 send a request to: Dr.Faessel@onthemar.com
Disclaimer; I own shares in Star Scientific
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.